Mendus : Interim Report January - March 2024
English Swedish ...
Stay updated with breaking news from Erik Manting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release Stockholm, Sweden, March 12, 2024 ADVANCE II Phase 2 trial data provide basis for late-stage development of lead product vididencel in acute myeloid leukemiaRegistration trial...
Press release Stockholm, Sweden, February 27, 2024 Mendus AB , a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the...
23.02.2024 - Press Release Stockholm, Sweden, February 23, 2024 Mendus AB (“Mendus” publ; IMMU.ST), will hold an in-person and live-streamed business update event in Stockholm on March 12, 15:00-17:00 CET to discuss the company’s latest pipeline ...
Mendus AB , will publish its year-end report for 2023 on Wednesday 14 February 2024 at 08:00 CET. The company will hold a conference call and an online presentation on the same day at 10:00 CET. The...